p38
p38 (p38 mitogen-activated protein kinases) are serine/threonine kinases that activated by environmental stress and proinflammatory cydtokines. They mediates cell growth, differentiation, transcrption and development.
p38 相关产品(100)
- GA20623Muramyl dipeptideCAS: 53678-77-6纯度: >99.00%
Muramyl dipeptide (MDP)，是一种合成的免疫反应肽 (immunoreactive peptide)，由 N-乙酰壁酸与 L-Ala-D-isoGln 的短氨基酸链相连。
- GC14645PF-3644022CAS: 1276121-88-0纯度: >99.50%
PF-3644022 是一种有效的、选择性的、具有口服活性和 ATP 竞争性的 MAPKAPK2 (MK2) 抑制剂，IC50 为 5.2 nM，Ki 为 3 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC12926 | VX-745 | 209410-46-8 | >99.00% / >98.00% | |
A p38α MAPK inhibitor | ||||
| GC16543 | TAK-715 | 303162-79-0 | >98.00% | |
TAK-715是一种高效，具有选择性和口服活性的p38 丝裂原活化蛋白激酶（p38 MAPK）抑制剂，对p38α和p38β的IC 50 值分别为7.1nM和200nM。 | ||||
| GC16835 | LY2228820 | 862507-23-1 | >99.50% | |
A potent inhibitor of p38α MAP kinase | ||||
| GC17508 | VX-702 | 745833-23-2 | >98.00% | |
An inhibitor of p38 MAP kinases | ||||
| GC17737 | PD 169316 | 152121-53-4 | >98.00% | |
A specific p38 MAPK inhibitor | ||||
| GA20623 | Muramyl dipeptide | 53678-77-6 | >99.00% | |
Muramyl dipeptide (MDP)，是一种合成的免疫反应肽 (immunoreactive peptide)，由 N-乙酰壁酸与 L-Ala-D-isoGln 的短氨基酸链相连。 | ||||
| GC10261 | PH-797804 | 586379-66-0 | >98.50% | |
A selective p38 MAPK inhibitor | ||||
| GC10403 | EO 1428 | 321351-00-2 | - | |
An inhibitor of p38α and p38β MAP kinases | ||||
| GC10593 | BMS-582949 hydrochloride | 912806-16-7 | >98.00% | |
A p38α MAP kinase inhibitor | ||||
| GC11180 | CMPD-1 | 41179-33-3 | >99.00% | |
A substrate-selective p38α MAPK inhibitor | ||||
| GC11497 | BIRB 796 (Doramapimod) | 285983-48-4 | >99.50% | |
A potent inhibitor of p38 MAPK | ||||
| GC11635 | TA 02 | 1784751-19-4 | >99.50% | |
An inducer of cardiomyocyte differentiation | ||||
| GC11857 | Pexmetinib (ARRY-614) | 945614-12-0 | >98.00% | |
A dual inhibitor of Tie2 and p38 MAPK | ||||
| GC11922 | SB 706504 | 911110-38-8 | - | |
p38 MAPK inhibitor | ||||
| GC12646 | AL 8697 | 1057394-06-5 | >99.00% | |
AL 8697 是一种具有口服活性的特异性 p38α MAPK 抑制剂，IC50 为 6 nM。 | ||||
| GC13116 | JX 401 | 349087-34-9 | - | |
A potent, reversible inhibitor of p38α MAPK | ||||
| GC13142 | RWJ 67657 | 215303-72-3 | >99.00% | |
An orally active inhibitor of p38α and p38β | ||||
| GC13578 | Skepinone-L | 1221485-83-1 | >99.50% | |
An inhibitor of p38 MAPK | ||||
| GC13595 | SB 203580 | 152121-47-6 | >98.00% / >99.00% | |
SB 203580是p38-MAPK（有丝分裂原活化蛋白激酶）通路的特异性抑制剂。 | ||||
| GC13825 | TA 01 | 1784751-18-3 | >99.50% | |
An inducer of cardiomyocyte differentiation | ||||
| GC14645 | PF-3644022 | 1276121-88-0 | >99.50% | |
PF-3644022 是一种有效的、选择性的、具有口服活性和 ATP 竞争性的 MAPKAPK2 (MK2) 抑制剂，IC50 为 5.2 nM，Ki 为 3 nM。 | ||||
| GC14899 | AMG 548 | 864249-60-5 | - | |
An inhibitor of p38α MAPK | ||||
| GC14982 | SD 169 | 1670-87-7 | >99.00% | |
A selective inhibitor of p38α and p38β MAP kinase | ||||
| GC15477 | DBM 1285 dihydrochloride | - | - | |
p38 MAPK inhibitor | ||||